The Urokinase-receptor (CD87) Is Expressed in Cells of the Megakaryoblastic Lineage
暂无分享,去创建一个
K. Preissner | S. Kanse | A. Eldor | K. Wohn | V. Deutsch | Thomas Schmidt
[1] R. Stephens,et al. The urokinase receptor , 1998 .
[2] P. Carmeliet,et al. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] K. Preissner,et al. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. , 1996, Experimental cell research.
[4] V. Gurewich,et al. Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. , 1996, Blood.
[5] T. McCaffrey,et al. THP‐1 macrophage membrane‐bound plasmin activity is up‐regulated by transforming growth factor‐β1 via increased expression of urokinase and the urokinase receptor , 1995 .
[6] K. Preissner,et al. The Versatility of Adhesion Receptor Ligands in Haemostasis: Morpho-Regulatory Functions of Vitronectin , 1995, Thrombosis and Haemostasis.
[7] R. Leven. Differential regulation of integrin‐mediated proplatelet formation and megakaryocyte spreading , 1995, Journal of cellular physiology.
[8] K. Danø,et al. The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. , 1995, Biological chemistry Hoppe-Seyler.
[9] G. Markus,et al. The induction of the plasminogen activator system during phorbol ester (PMA)-induced differentiation in HL-60 leukemic cells , 1995 .
[10] N. E. Hansen,et al. The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria , 1995, British journal of haematology.
[11] M. Kramer,et al. Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. , 1995, Biological chemistry Hoppe-Seyler.
[12] B. Jhun,et al. Tyrosine kinases in megakaryocytopoiesis , 1995, Stem cells.
[13] N. Brünner,et al. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion , 1995 .
[14] S. Rosenberg,et al. Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.
[15] H. Johnsen,et al. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. , 1994, American journal of clinical pathology.
[16] I. Juhan-vague,et al. Detection of Plasminogen Activator Inhibitor-1 (PAI-1) mRNA in Human Megakaryocytes by In Situ Hybridization , 1994, Thrombosis and Haemostasis.
[17] Y. Kook,et al. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. , 1994, The EMBO journal.
[18] William Vainchenker,et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.
[19] N. Altszuler,et al. Release of GPI‐anchored membrane proteins by a cell‐associated GPI‐specific phospholipase D. , 1994, The EMBO journal.
[20] U. Weidle,et al. Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA) , 1994, FEBS letters.
[21] U. Cavallaro,et al. The urokinase receptor: Structure, regulation and inhibitor-mediated internalization , 1994 .
[22] D. Lawrence,et al. Both pro-uPA and uPA: PAI-1 complex bind to the alpha 2-macroglobulin receptor/LDL receptor-related protein. Evidence for multiple independent contacts between the ligands and receptor. , 1994, Annals of the New York Academy of Sciences.
[23] R. Timpl,et al. Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. , 1993, The Journal of biological chemistry.
[24] D. Waltz,et al. Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. , 1993, The Journal of clinical investigation.
[25] J. Hoxie,et al. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways. , 1993, Circulation research.
[26] H. Avraham. Regulation of megakaryocytopoiesis , 1993, Stem cells.
[27] F. Tablin,et al. Extracellular matrix stimulation of guinea pig megakaryocyte proplatelet formation in vitro is mediated through the vitronectin receptor. , 1992, Experimental hematology.
[28] L. Lund,et al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. , 1992, The Journal of biological chemistry.
[29] I. Mizukami,et al. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. , 1992, Journal of immunology.
[30] N. E. Hansen,et al. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. , 1992, Blood.
[31] F. Blasi,et al. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion , 1991, The Journal of cell biology.
[32] R. Ware,et al. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. , 1991, The New England journal of medicine.
[33] J. Gabrilove,et al. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan , 1991, The Journal of cell biology.
[34] L. Lund,et al. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. , 1991, The Journal of biological chemistry.
[35] B. Coller,et al. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. , 1991, Blood.
[36] L. Lund,et al. The urokinase receptor and regulation of cell surface plasminogen activation. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[37] R. Leven,et al. Collagenase production by guinea pig megakaryocytes in vitro. , 1990, Experimental hematology.
[38] K. Preissner,et al. Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator. , 1990, Biochemical and biophysical research communications.
[39] E. Appella,et al. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. , 1990, The Journal of biological chemistry.
[40] E. Appella,et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.
[41] M. Lieberman,et al. In vitro establishment and characterization of a human megakaryoblastic cell line. , 1990, Blood.
[42] J. Freyssinet,et al. Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. , 1989, The Biochemical journal.
[43] Y. Sultan,et al. Tissue Plasminogen Activator in Human Megakaryocytes and Platelets: Immunocytochemical Localization, Immunoblotting and Zymographic Analysis , 1988, Thrombosis and Haemostasis.
[44] K. Preissner,et al. Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. , 1988, Blood.
[45] F. Blasi,et al. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. , 1988, The Journal of biological chemistry.
[46] B. Haendler,et al. Complementary DNA for human T‐cell cyclophilin. , 1987, The EMBO journal.
[47] A. Corti,et al. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[48] D. Belin,et al. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.
[49] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[50] C. Edgell,et al. Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[51] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.